Miacalcin and Dysuria aggravated - a phase IV clinical study of FDA data

Summary:

Dysuria aggravated is reported as a side effect among people who take Miacalcin (calcitonin, salmon), especially for people who are female, 60+ old, also take Fosamax, and have Osteopenia.

The phase IV clinical study analyzes which people have Dysuria aggravated when taking Miacalcin. It is created by eHealthMe based on reports of 5,414 people who have side effects when taking Miacalcin from the FDA, and is updated regularly.

What is Miacalcin?

Miacalcin has active ingredients of calcitonin, salmon. It is often used in osteoporosis. eHealthMe is studying from 5,437 Miacalcin users. Check the latest studies of Miacalcin.

What is Dysuria aggravated?

Dysuria aggravated (painful or difficult urination) is found to be associated with 1,199 drugs and 409 conditions by eHealthMe. Check the latest studies of Dysuria aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

5,414 people reported to have side effects when taking Miacalcin.
Among them, 47 people (0.87%) have Dysuria aggravated.

Could Miacalcin cause Dysuria aggravated?

Among these 47 people:

What is the gender of people who have Dysuria aggravated when taking Miacalcin? *

female: 95.65 %
male: 4.35 %

What is the age of people who have Dysuria aggravated when taking Miacalcin? *

What are other drugs people take besides Miacalcin? *

What are other side effects people have besides Dysuria aggravated? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 25 people, 53.19%
Stress And Anxiety: 23 people, 48.94%
Fall: 19 people, 40.43%
Anaemia (lack of blood): 19 people, 40.43%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 17 people, 36.17%
Hyperlipidaemia (presence of excess lipids in the blood): 17 people, 36.17%
Back Pain: 17 people, 36.17%
Swallowing Difficulty: 17 people, 36.17%
Squamous Cell Carcinoma Of Skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin): 16 people, 34.04%
Pain: 15 people, 31.91%

What are the existing conditions these people have? *

Osteopenia (a condition where bone mineral density is lower than normal): 16 people, 34.04%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 4.26%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 4.26%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 4.26%
Ill-Defined Disorder: 2 people, 4.26%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 2.13%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 1 person, 2.13%
Renal Cell Carcinoma (a kidney cancer): 1 person, 2.13%
Quit Smoking: 1 person, 2.13%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Miacalcin and have Dysuria aggravated?

- Check whether Dysuria aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Miacalcin:

Miacalcin (5,437 reports)

Browse all side effects of Miacalcin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dysuria aggravated:

Dysuria aggravated (1,200 drugs)

Browse all the conditions that are associated with Dysuria aggravated:

Dysuria aggravated (409 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on calcitonin, salmon (the active ingredients of Miacalcin) and Miacalcin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.